Akari Therapeutics, Plc
Price
FilingsNewest: 8-K, Director or officer changeOct 1 →InsidersNo open-market buys or sales.→HoldersMMCAP International Inc. SPC 0.0%Cresset 0.0%Jane Street 0.0%→Financing →PeersClosest companies: CMPX, ERAS, IDYA→
From the filings
Figures
- Net income
- −$31.0Mlast 12 months
- Operating cash flow
- −$10.9Mlast 12 months
- Cash and equivalents
- $7.7Mat the last balance sheet
- Shares outstanding
- 140.03B shareson issue